Lack of AD pathology in our MS population serves as one possible explanation for the different relation of tau protein to brain atrophy, i.e. loss of brain volume with the increase of t-tau in CSF in AD, and the decrease of t-tau in CSF in MS. Here, MAPT is linked to myeloid sarcoma.